GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » Other Stockholders Equity

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Other Stockholders Equity : $0.50 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Other Stockholders Equity?

TC BioPharm (Holdings)'s Other Stockholders Equity for the quarter that ended in Mar. 2024 was $0.50 Mil.

TC BioPharm (Holdings)'s quarterly Other Stockholders Equity increased from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($0.50 Mil) and increased from Dec. 2023 ($0.50 Mil) to Mar. 2024 ($0.50 Mil).

TC BioPharm (Holdings)'s annual Other Stockholders Equity declined from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-19.87 Mil) but then increased from Dec. 2022 ($-19.87 Mil) to Dec. 2023 ($0.50 Mil).


TC BioPharm (Holdings) Other Stockholders Equity Historical Data

The historical data trend for TC BioPharm (Holdings)'s Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Other Stockholders Equity Chart

TC BioPharm (Holdings) Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
- - - -19.87 0.50

TC BioPharm (Holdings) Quarterly Data
Dec19 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.87 - - 0.50 0.50

TC BioPharm (Holdings) Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


TC BioPharm (Holdings) Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Traded in Other Exchanges
Address
Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.
Executives
Renaissance Capital Partners Ltd 10 percent owner 42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall 10 percent owner C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD